Judith Dams
Dr. rer. med.
Judith Dams
  • Head of working group
Working area

Location

W37 , 6th Floor, Room number 609
Languages
German (Mother tongue)
English

Curriculum vitae

Publications

Zurück
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2013
  • 2012
  • 2011
  • 2010
Vor

Mental Health Self-Stigma of Syrian Refugees With Posttraumatic Stress Symptoms: Investigating Sociodemographic and Psychopathological Correlates
Bär J, Pabst A, Röhr S, Luppa M, Renner A, Nagl M, Dams J, Grochtdreis T, Kersting A, König H, Riedel-Heller S
Front Psychiatry. 2021;12:642618.

German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life
Dams J, Huynh E, Riedel-Heller S, Löbner M, Brettschneider C, König H
EUR J HEALTH ECON. 2021;22(3):365-380.

Reliability, Validity and Responsiveness of the EQ-5D-5L in Assessing and Valuing Health Status in Adolescents and Young Adults with Posttraumatic Stress Disorder: a Randomized Controlled Trail
Dams J, Rimane E, Steil R, Renneberg B, Rosner R, König H
PSYCHIAT QUART. 2021;92(2):459-471.

Health-Related Quality of Life of Persons with Direct, Indirect and No Migration Background in Germany: A Cross-Sectional Study Based on the German Socio-Economic Panel (SOEP)
Grochtdreis T, König H, Dams J
INT J ENV RES PUB HE. 2021;18(7):3665.

Health Care Services Utilization and Health-Related Quality of Life of Syrian Refugees with Post-Traumatic Stress Symptoms in Germany (the Sanadak Trial)
Grochtdreis T, Röhr S, Jung F, Nagl M, Renner A, Kersting A, Riedel-Heller S, König H, Dams J
INT J ENV RES PUB HE. 2021;18(7):.

Valuing end-of-life care: translation and content validation of the ICECAP-SCM measure
Gühne U, Dorow M, Grothe J, Stein J, Löbner M, Dams J, Coast J, Kinghorn P, König H, Riedel-Heller S
BMC PALLIAT CARE. 2021;20(1):29.

Berufliche Teilhabe von syrischen Geflüchteten mit posttraumatischer Stress-Symptomatik in Deutschland
Gühne U, Jung F, Röhr S, Pabst A, Grochtdreis T, Dams J, Renner A, Nagl M, Kersting A, König H, Riedel-Heller S
PSYCHIAT PRAX. 2021 [Epub ahead of print].

Lifestyle-integrated functional exercise to prevent falls and promote physical activity: Results from the LiFE-is-LiFE randomized non-inferiority trial
Jansen C, Nerz C, Labudek S, Gottschalk S, Kramer-Gmeiner F, Klenk J, Dams J, König H, Clemson L, Becker C, Schwenk M
INT J BEHAV NUTR PHY. 2021;18(1):115.

Predictors of psychological distress in Syrian refugees with posttraumatic stress in Germany
Renner A, Jäckle D, Nagl M, Hoffmann R, Röhr S, Jung F, Grochtdreis T, Dams J, König H, Riedel-Heller S, Kersting A
PLOS ONE. 2021;16(8):e0254406.

Traumatized Syrian Refugees with Ambiguous Loss: Predictors of Mental Distress
Renner A, Jäckle D, Nagl M, Plexnies A, Röhr S, Löbner M, Grochtdreis T, Dams J, König H, Riedel-Heller S, Kersting A
INT J ENV RES PUB HE. 2021;18(8):3865.

A Self-Help App for Syrian Refugees With Posttraumatic Stress (Sanadak): Randomized Controlled Trial
Röhr S, Jung F, Pabst A, Grochtdreis T, Dams J, Nagl M, Renner A, Hoffmann R, König H, Kersting A, Riedel-Heller S
JMIR MHEALTH UHEALTH. 2021;9(1):e24807.

Correction: A Self-Help App for Syrian Refugees With Posttraumatic Stress (Sanadak): Randomized Controlled Trial
Röhr S, Jung F, Pabst A, Grochtdreis T, Dams J, Nagl M, Renner A, Hoffmann R, König H, Kersting A, Riedel-Heller S
JMIR MHEALTH UHEALTH. 2021;9(3):e28336.

Patient-Centered Placement Matching of Alcohol-Dependent Patients Based on a Standardized Intake Assessment: Primary Outcomes of an Exploratory Randomized Controlled Trial
Buchholz A, Dams J, Rosahl A, Hempleman J, König H, Konnopka A, Kraus L, Kriston L, Piontek D, Reimer J, Röhrig J, Scherbaum N, Silkens A, Berner M
EUR ADDICT RES. 2020;26(3):109-121.

Health-Related Quality of Life and Costs of Posttraumatic Stress Disorder in Adolescents and Young Adults in Germany
Dams J, Rimane E, Steil R, Renneberg B, Rosner R, König H
Front Psychiatry. 2020;11:697.

Psychometric Properties of the EQ-5D for the Assessment of Health-Related Quality of Life in the Population of Middle-Old and Oldest-Old Persons: Study Protocol for a Systematic Review
Gottschalk S, König H, Nejad M, Dams J
Front Public Health. 2020;8:578073.

Mediating factors on the association between fear of falling and health-related quality of life in community-dwelling German older people: a cross-sectional study
Gottschalk S, König H, Schwenk M, Jansen C, Nerz C, Becker C, Klenk J, Dams J
BMC GERIATR. 2020;20(1):401.

Health-Related Quality of Life of Asylum Seekers and Refugees in Germany: a Cross-Sectional Study with Data from the German Socio-Economic Panel
Grochtdreis T, König H, Riedel-Heller S, Dams J
APPL RES QUAL LIFE. 2020 [Epub ahead of print].

Recruitment and Baseline Characteristics of Participants in the "Sanadak" Trial: A Self-Help App for Syrian Refugees with Post-traumatic Stress
Röhr S, Jung F, Renner A, Plexnies A, Hoffmann R, Dams J, Grochtdreis T, König H, Kersting A, Riedel-Heller S
INT J ENV RES PUB HE. 2020;17(20):7578.

Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review
von der Warth R, Dams J, Grochtdreis T, König H
EUR J PSYCHOTRAUMATO. 2020;11(1):1753940.

Direkte Kosten sozialer Angststörung bei Jugendlichen und Kosteneffektivität der Psychotherapie
Dams J, Kronmüller K, Leibing E, Steil R, Henningsen P, Leichsenring F, Peseschkian H, Rosner R, Salzer S, Stefini A, Vonderlin E, König H
PSYCHIAT PRAX. 2019;46(3):148-155.

Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set
Grochtdreis T, Dams J, König H, Konnopka A
EUR J HEALTH ECON. 2019;20(6):933-944.

Effect of Naturally Occurring α-Synuclein-Antibodies on Toxic α-Synuclein-Fragments
Rabenstein M, Agbo D, Wolf E, Dams J, Nicolai M, Roeder A, Bacher M, Dodel R, Noelker C
NEUROSCI LETT. 2019;704:181-188.

Strategien zur Rekrutierung von Geflüchteten für Interventionsstudien: Erkenntnisse aus dem „Sanadak“-Trial
Roehr S, Wittmann F, Jung F, Hoffmann R, Renner A, Dams J, Grochtdreis T, Kersting A, König H, Riedel-Heller S
PSYCHOTHER PSYCH MED. 2019;69(12):484-489.

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition
Wojtala J, Heber I, Neuser P, Heller J, Kalbe E, Rehberg S, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen H, Riedel O, Dodel R, Schulz J, Reetz K
J NEUROL NEUROSUR PS. 2019;90(2):171-179.

Excess costs of alcohol-dependent patients in German psychiatric care compared with matched non-alcohol-dependent individuals from the general Population: a secondary analysis of two datasets
Dams J, Buchholz A, Kraus L, Reimer J, Scherbaum N, Konnopka A, König H
BMJ OPEN. 2018;8:e020563.

Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
Grochtdreis T, König H, Dobruschkin A, von Amsberg G, Dams J
PLOS ONE. 2018;13(12):e0208063.

Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial)
Grochtdreis T, Zimmermann T, Puschmann E, Porzelt S, Dams J, Scherer M, König H
INT J NURS STUD. 2018;80:67-75.

Comparison of a group-delivered and individually delivered lifestyle-integrated functional exercise (LiFE) program in older persons: a randomized noninferiority trial
Jansen C, Nerz C, Kramer F, Labudek S, Klenk J, Dams J, König H, Clemson L, Becker C, Schwenk M
BMC GERIATR. 2018;18(1):267.

Costs of Illness in Chronic Inflammatory Demyelinating Polyneuropathy in Germany
Mengel D, Fraune L, Sommer N, Stettner M, Reese J, Dams J, Glynn R, Balzer-Geldsetzer M, Dodel R, Tackenberg B
MUSCLE NERVE. 2018;58(5):681-687.

Excess costs of social anxiety disorder in Germany
Dams J, König H, Bleibler F, Hoyer J, Wiltink J, Beutel M, Salzer S, Herpertz S, Willutzki U, Strauß B, Leibing E, Leichsenring F, Konnopka A
J AFFECT DISORDERS. 2017;213:23-29.

19 Kosten-Nutzen-Analysen zur tiefen Hirnstimulation bei Patienten mit idiopathischem Parkinson-Syndrom
Dodel R, Dams J, Reese J
2017. Tiefe Hirnstimulation. 1. ed. Berlin: De Gryter, 181-192.

Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications
Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach W, Krack P, Timmermann L, Schnitzler A, Reese J, Dodel R
MOVEMENT DISORD. 2016;31(8):1183-91.

An economic evaluation of deep brain stimulation for patients with Parkinson's disease
Dams J, Dodel R
MOVEMENT DISORD. 2016;31(8):1122-1124.

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data
Fengler S, Roeske S, Heber I, Reetz K, Schulz J, Riedel O, Wittchen H, Storch A, Linse K, Baudrexel S, Hilker R, Mollenhauer B, Witt K, Schmidt N, Balzer-Geldsetzer M, Dams J, Dodel R, Gräber S, Pilotto A, Petrelli A, Fünkele S, Kassubek J, Kalbe E
PSYCHOL MED. 2016;46(11):2275-2286.

Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings
Heßmann P, Seeberg G, Reese J, Dams J, Baum E, Müller M, Dodel R, Balzer-Geldsetzer M
J ALZHEIMERS DIS. 2016;51(2):545-561.

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study
Kalbe E, Rehberg S, Heber I, Kronenbuerger M, Schulz J, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen H, Riedel O, Dodel R
J NEUROL NEUROSUR PS. 2016;87(10):1099-1105.

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease
Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen H, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz J, Reetz K, Heber I, Ramirez A, Dodel R
PARKINSONISM RELAT D. 2016;29:112-6.

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease
Dams J, Klotsche J, Bornschein B, Reese J, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel W, Deuschl G, Siebert U, Dodel R
HEALTH QUAL LIFE OUT. 2013;11:35.

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
Dams J, Siebert U, Bornschein B, Volkmann J, Deuschl G, Oertel W, Dodel R, Reese J
MOVEMENT DISORD. 2013;28(6):763-771.

Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses
Pouryamout L, Dams J, Wasem J, Dodel R, Neumann A
DRUGS. 2012;72(6):789-802.

Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease
Reese J, Dams J, Winter Y, Balzer-Geldsetzer M, Oertel W, Dodel R
EXPERT OPIN PHARMACO. 2012;13(7):939-958.

Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review
Dams J, Bornschein B, Reese J, Conrads-Frank A, Oertel W, Siebert U, Dodel R
PHARMACOECONOMICS. 2011;29(12):1025-1049.

Health-related quality of life in patients with subarachnoid haemorrhage
Meyer B, Ringel F, Winter Y, Spottke A, Gharevi N, Dams J, Balzer-Geldsetzer M, Mueller I, Klockgether T, Schramm J, Urbach H, Dodel R
CEREBROVASC DIS. 2010;30(4):423-431.

Letzte Aktualisierung aus dem FIS: 28.09.2021 - 04:12 Uhr